0 135

Cited 0 times in

Durvalumab +/− Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase III POSEIDON Study

Authors
 N Reinmuth  ;  M L Johnson  ;  B C Cho  ;  A Luft  ;  J A Alatorre-Alexander  ;  S L Geater  ;  K Laktionov  ;  A Vasilyev  ;  D Trukhin  ;  S W Kim  ;  G Ursol  ;  M Hussein  ;  F L Lim  ;  C T Yang  ;  L H Araujo  ;  H Saito  ;  X Shi  ;  L Poole  ;  S Peters  ;  E B Garon  ;  T Mok  ;  J Rawluk 
Citation
 PNEUMOLOGIE, Vol.76(Suppl 1) : S48, 2022-05 
Journal Title
 PNEUMOLOGIE 
Issue Date
2022-05
Full Text
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0042-1747796
DOI
10.1055/s-0042-1747796
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194456
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links